The Long View cover image

Eric Schoenstein: The Case for Quality Stocks

The Long View

00:00

The Cost of Doing Business in the Health Care Space

In the last three years or so, we've seen a little over 300 million dollars that the company has paid out for recalls. They're trying enoh, f you think about their orthopetic business, you're trying to solve issues related to essentially replacing human anatomy. That is not an endeavor that should be thought of as a zero defect.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app